MedPath

Efficacy of Combined Scaffolds and Sodium Hypochlorite in Regenerative Endodontics of Immature Teeth

Not Applicable
Recruiting
Conditions
Incomplete Root Formation of Anterior Teeth
Interventions
Other: Intra-canal medication protocol
Registration Number
NCT05803525
Lead Sponsor
Tanta University
Brief Summary

The aim of the study is to evaluate the efficacy of combinations of different scaffolds (blood clot, platelet rich fibrin, collagen) and sodium hypochlorite concentrations (0.5%- 2.5%) in regenerative endodontics of immature non-vital anterior teeth clinically and radiographically using cone-beam computed tomography.

Detailed Description

Patients will be divided randomly into six equal groups (n=8)

* Group I: BC scaffold and 0.5% concentration of NaOCl irrigant solution.

* Group II: BC scaffold and 2.5% concentration of NaOCl irrigant solution.

* Group III: PRF scaffold and 0.5% concentration of NaOCl irrigant solution.

* Group IV: PRF scaffold and 2.5% concentration of NaOCl irrigant solution.

* Group V: Collagen scaffold and 0.5% concentration of NaOCl irrigant solution.

* Group VI: Collagen scaffold and 2.5% concentration of NaOCl irrigant solution.

CBCT image will be obtained for baseline records after placement of the final resin restoration then the patients will be recalled after 6 months and 12 months for evaluating any changes in root length, root canal width, apex diameter and lesion size if present. The success rates for patients at each recall visit will be scored as follows

1. Score 0: Persistence of clinical and radiographic findings.

2. Score 1: Absence of swelling, drainage and pain along with radiographic evidence of osseous healing + no evidence of increased root dimensions.

3. Score 2: Absence of swelling, drainage and pain along with radiographic evidence of osseous healing + radiographic root development.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
48
Inclusion Criteria
  • • Patients, abarantly free from any systemic diseases that may hinder the normal healing process.

    • Maxillary traumatized or cariously exposed immature anterior teeth.
    • Clinical signs of pulp necrosis.
    • Radiographic evidence of incomplete root development based on an apical opening >1 mm.
Exclusion Criteria
  • • Allergy to medication used in the procedure or any medical conditions that contraindicate endodontic treatment (eg, acute systemic disease and abnormalities in host defense).

    • Non-restorable tooth.
    • Radiographic evidence of root fracture.
    • Lack of patient and parent cooperation.
    • Teeth with vital pulps and complete root development.
    • Presence of periodontal pocket > 4 mm.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
• Group II: BC scaffold and 2.5% concentration of NaOCl irrigant solution. •Intra-canal medication protocolBC will be made \& use 2.5 NaOCl conc
• Group I: BC scaffold and 0.5% concentration of NaOCl irrigant solution.Intra-canal medication protocolBC will be made \& use 0.5 NaOCl conc
• Group III: PRF scaffold and 0.5% concentration of NaOCl irrigant solution. •Intra-canal medication protocolPRF will be made \& use 0.5 NaOCl conc
• Group VI: Collagen scaffold and 2.5% concentration of NaOCl irrigant solution.Intra-canal medication protocolCollagen will be made \& use 2.5 NaOCl conc
Group IV: PRF scaffold and 2.5% concentration of NaOCl irrigant solution. •Intra-canal medication protocolPRF will be made \& use 2.5 NaOCl conc
• Group V: Collagen scaffold and 0.5% concentration of NaOCl irrigant solution.Intra-canal medication protocolCollagen will be made \& use 0.5 NaOCl conc
Primary Outcome Measures
NameTimeMethod
diameter of periapical radiolucency1 year

radiographic changes in root

diameter of root length1 year

radiographic changes in root

Secondary Outcome Measures
NameTimeMethod
Pain scale1 year
visual changes in discoloration1 year

Trial Locations

Locations (1)

Faculty of Dentistry, Tanta University

🇪🇬

Tanta, Egypt

© Copyright 2025. All Rights Reserved by MedPath